These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32647118)

  • 1. Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8-MCM9 complex and compromises DNA mismatch repair in cancer cells.
    Liu K; Wang Y; Zhu Q; Li P; Chen J; Tang Z; Shen Y; Cheng X; Lu LY; Liu Y
    Cell Death Dis; 2020 Jul; 11(7):519. PubMed ID: 32647118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meiotic cohesins mediate initial loading of HORMAD1 to the chromosomes and coordinate SC formation during meiotic prophase.
    Fujiwara Y; Horisawa-Takada Y; Inoue E; Tani N; Shibuya H; Fujimura S; Kariyazono R; Sakata T; Ohta K; Araki K; Okada Y; Ishiguro KI
    PLoS Genet; 2020 Sep; 16(9):e1009048. PubMed ID: 32931493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM9 Is Required for Mammalian DNA Mismatch Repair.
    Traver S; Coulombe P; Peiffer I; Hutchins JR; Kitzmann M; Latreille D; Méchali M
    Mol Cell; 2015 Sep; 59(5):831-9. PubMed ID: 26300262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopically Expressed Meiosis-Specific Cancer Testis Antigen HORMAD1 Promotes Genomic Instability in Squamous Cell Carcinomas.
    Gantchev J; Messina-Pacheco J; Martínez Villarreal A; Ramchatesingh B; Lefrançois P; Xie P; Amar L; Xu HH; Raveendra K; Sikorski D; Guerra Ordaz DJ; Gill RPK; Lambert M; Litvinov IV
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MCM8-MCM9 complex promotes RAD51 recruitment at DNA damage sites to facilitate homologous recombination.
    Park J; Long DT; Lee KY; Abbas T; Shibata E; Negishi M; Luo Y; Schimenti JC; Gambus A; Walter JC; Dutta A
    Mol Cell Biol; 2013 Apr; 33(8):1632-44. PubMed ID: 23401855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells.
    Gao Y; Kardos J; Yang Y; Tamir TY; Mutter-Rottmayer E; Weissman B; Major MB; Kim WY; Vaziri C
    Sci Rep; 2018 Oct; 8(1):15304. PubMed ID: 30333500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repair of exogenous DNA double-strand breaks promotes chromosome synapsis in SPO11-mutant mouse meiocytes, and is altered in the absence of HORMAD1.
    Carofiglio F; Sleddens-Linkels E; Wassenaar E; Inagaki A; van Cappellen WA; Grootegoed JA; Toth A; Baarends WM
    DNA Repair (Amst); 2018 Mar; 63():25-38. PubMed ID: 29414051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCM8- and MCM9-deficient mice reveal gametogenesis defects and genome instability due to impaired homologous recombination.
    Lutzmann M; Grey C; Traver S; Ganier O; Maya-Mendoza A; Ranisavljevic N; Bernex F; Nishiyama A; Montel N; Gavois E; Forichon L; de Massy B; Méchali M
    Mol Cell; 2012 Aug; 47(4):523-34. PubMed ID: 22771120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mammalian HORMA domain-containing protein, HORMAD1, preferentially associates with unsynapsed meiotic chromosomes.
    Fukuda T; Daniel K; Wojtasz L; Toth A; Höög C
    Exp Cell Res; 2010 Jan; 316(2):158-71. PubMed ID: 19686734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and biochemical insights into the interaction mechanism underlying HORMAD1 and its partner proteins.
    Wang H; Xie R; Niu F; Yang Q; An L; Wu C; Liu X; Yang X
    Structure; 2023 Dec; 31(12):1578-1588.e3. PubMed ID: 37794593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cancer testes antigen, HORMAD1, limits genomic instability in cancer cells by protecting stalled replication forks.
    Herrera LR; Johnson RA; McGlynn K; Gibbs ZA; Davis AJ; Whitehurst AW
    J Biol Chem; 2023 Nov; 299(11):105348. PubMed ID: 37838177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCM8-9 complex promotes resection of double-strand break ends by MRE11-RAD50-NBS1 complex.
    Lee KY; Im JS; Shibata E; Park J; Handa N; Kowalczykowski SC; Dutta A
    Nat Commun; 2015 Jul; 6():7744. PubMed ID: 26215093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes.
    Kogo H; Tsutsumi M; Ohye T; Inagaki H; Abe T; Kurahashi H
    Genes Cells; 2012 Jun; 17(6):439-54. PubMed ID: 22530760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meiotic homologue alignment and its quality surveillance are controlled by mouse HORMAD1.
    Daniel K; Lange J; Hached K; Fu J; Anastassiadis K; Roig I; Cooke HJ; Stewart AF; Wassmann K; Jasin M; Keeney S; Tóth A
    Nat Cell Biol; 2011 May; 13(5):599-610. PubMed ID: 21478856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular functions of MCM8 and MCM9 and their associated pathologies.
    Helderman NC; Terlouw D; Bonjoch L; Golubicki M; Antelo M; Morreau H; van Wezel T; Castellví-Bel S; Goldberg Y; Nielsen M
    iScience; 2023 Jun; 26(6):106737. PubMed ID: 37378315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting the MCM8-9 complex selectively sensitizes cancer cells to cisplatin and olaparib.
    Morii I; Iwabuchi Y; Mori S; Suekuni M; Natsume T; Yoshida K; Sugimoto N; Kanemaki MT; Fujita M
    Cancer Sci; 2019 Mar; 110(3):1044-1053. PubMed ID: 30648820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress.
    Nichols BA; Oswald NW; McMillan EA; McGlynn K; Yan J; Kim MS; Saha J; Mallipeddi PL; LaDuke SA; Villalobos PA; Rodriguez-Canales J; Wistuba II; Posner BA; Davis AJ; Minna JD; MacMillan JB; Whitehurst AW
    Cancer Res; 2018 Nov; 78(21):6196-6208. PubMed ID: 30185546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency.
    Desai S; Wood-Trageser M; Matic J; Chipkin J; Jiang H; Bachelot A; Dulon J; Sala C; Barbieri C; Cocca M; Toniolo D; Touraine P; Witchel S; Rajkovic A
    J Clin Endocrinol Metab; 2017 Feb; 102(2):576-582. PubMed ID: 27802094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors.
    Lutzmann M; Bernex F; da Costa de Jesus C; Hodroj D; Marty C; Plo I; Vainchenker W; Tosolini M; Forichon L; Bret C; Queille S; Marchive C; Hoffmann JS; Méchali M
    Cell Rep; 2019 Sep; 28(11):2851-2865.e4. PubMed ID: 31509747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of homologous recombination by the HROB-MCM8-MCM9 pathway.
    Hustedt N; Saito Y; Zimmermann M; Álvarez-Quilón A; Setiaputra D; Adam S; McEwan A; Yuan JY; Olivieri M; Zhao Y; Kanemaki MT; Jurisicova A; Durocher D
    Genes Dev; 2019 Oct; 33(19-20):1397-1415. PubMed ID: 31467087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.